Involvement of the β-adrenergic system in the cardiac chronic form of experimental Trypanosoma cruzi infection

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Parasitology

• Publication date

  2009-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1017/S0031182009006337PMID 19523250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• β-1 and β-2 adrenoceptor polymorphisms : Functional importance, impact on cardiovascular diseases and drug responses

  2008cited by this paper
• Cross-talk between anti-β1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease

  2008cited by this paper
• Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses.

  2008cited by this paper
• Some components of the cardiac β-adrenergic system are altered in the chronic indeterminate form of experimental Trypanosoma cruzi infection.

  2008influential reference
• Risk stratification.

  2008cited by this paper
• Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.

  2007cited by this paper
• Chagas disease: what is known and what is needed--a background article.

  2007cited by this paper
• Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease.

  2007cited by this paper
• Anti‐β1‐adrenergic receptor autoantibodies in patients with chronic Chagas heart disease

  2007cited by this paper
• Evolution and pathology in chagas disease--a review.

  2006influential reference
• The real estate of cardiac signaling: Location, location, location

  2006cited by this paper
• Characterization of cardiopulmonary function and cardiac muscarinic and adrenergic receptor density adaptation in C57BL/6 mice with chronic Trypanosoma cruzi infection

  2006cited by this paper
• Changes in the cardiac β-adrenergic system provoked by different T. cruzi strains

  2006influential reference
• Changes in the cardiac beta-adrenergic system provoked by different T. cruzi strains.

  2006cited by this paper
• beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy.

  2006cited by this paper
• Different signaling pathways are involved in cardiomyocyte survival induced by a Trypanosoma cruzi glycoprotein.

  2006cited by this paper
• Trypanosoma cruzi disrupts myofibrillar organization and intracellular calcium levels in mouse neonatal cardiomyocytes

  2006cited by this paper
• Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.

  2005cited by this paper
• Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy.

  2005cited by this paper
• The β1 adrenergic effects of antibodies against the C‐terminal end of the ribosomal P2β protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition

  2005cited by this paper
• Network integration of the adrenergic system in cardiac hypertrophy.

  2004cited by this paper
• Mechanisms of β-adrenergic receptor desensitization: from molecular biology to heart failure

  2004cited by this paper
• Congestive heart failure in Latin America: the next epidemic.

  2004cited by this paper
• beta(2)-Adrenergic receptor signaling complexes in cardiomyocyte caveolae/lipid rafts.

  2004cited by this paper
• The adrenergic pathway and heart failure.

  2004cited by this paper
• Cruzipain induces autoantibodies against cardiac muscarinic acetylcholine receptors. Functional and pathological implications

  2003cited by this paper
• Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.

  2003cited by this paper
• The trypanosomiases.

  2003influential reference
• Trypanosoma cruzi reinfections provoke synergistic effect and cardiac beta-adrenergic receptors' dysfunction in the acute phase of experimental Chagas' disease.

  2003cited by this paper
• Control of Chagas disease.

  2002influential reference
• Cardiac hypertrophy: role of G protein-coupled receptors.

  2002cited by this paper
• Cardiac autonomic denervation in congestive heart failure: comparison of Chagas' heart disease with other dilated cardiomyopathy.

  2000cited by this paper
• beta-adrenergic mechanisms in cardiac diseases: a perspective.

  2000influential reference
• Autoantibodies against the Beta- and Muscarinic Receptors in Cardiomyopathy

  2000cited by this paper
• Chagas' Heart Disease

  2000cited by this paper
• β-adrenergic mechanisms in cardiac diseases:

  2000influential reference
• Regulation of beta-adrenoceptor signaling in cardiac function and disease.

  1999cited by this paper
• Chagas disease etiology: autoimmunity or parasite persistence?

  1999cited by this paper
• Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.

  1999cited by this paper
• Regulation of β-Adrenoceptor Signaling in Cardiac Function and Disease

  1999influential reference
• LA MIOCARDIOPATIA CHAGASICA PERSPECTIVA HISTÓRICA

  1999cited by this paper
• Overview of molecular mechanisms in chagasic cardioneuromyopathy and achalasia.

  1999cited by this paper
• [Chagasic myocardiopathy: historical perspective].

  1999cited by this paper
• Regulation of b-Adrenoceptor Signaling in Cardiac Function and Disease

  1999influential reference
• Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy.

  1997cited by this paper
• [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].

  1996cited by this paper
• Trypanosoma cruzi: paninfectivity of CL strain during murine acute infection.

  1996cited by this paper
• Characterization of Trypanosoma cruzi populations by zymodemes: correlation with clinical picture.

  1996cited by this paper
• Autoimmunity in chagas disease cardiomyopathy: Fulfilling the criteria at last?

  1996cited by this paper
• Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

  1995cited by this paper
• A trypanosome-soluble factor induces IP3 formation, intracellular Ca2+ mobilization and microfilament rearrangement in host cells

  1995cited by this paper
• The two-state model of receptor activation.

  1995cited by this paper
• Mechanisms of beta adrenoceptor desensitisation in the failing human heart.

  1994cited by this paper
• Congestive Heart Failure

  1994cited by this paper
• Mechanisms of β adrenoceptor desensitisation in the failing human heart

  1994cited by this paper
• Participation of autonomic nervous system in the pathogenesis of Chagas disease.

  1994influential reference
• Changes in myocardial and vascular receptors in heart failure.

  1993cited by this paper
• Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins.

  1993cited by this paper
• Quantification of Trypanosoma cruzi in the heart, lymph nodes and liver of experimentally infected mice, using limiting dilution analysis.

  1992cited by this paper
• Cardiac levels of norepinephrine, dopamine, serotonin and histamine in Chagas' disease.

  1991cited by this paper
• Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

  1991cited by this paper
• Plasma norepinephrine in Chagas' cardioneuromyopathy: a marker of progressive dysautonomia.

  1989cited by this paper
• The Role of active myocarditis in the development of heart failure in chronic chagas' disease: A study based on endomyocardial biopsies

  1987cited by this paper
• Is there autoimmunity in Chagas disease?

  1985cited by this paper
• Experimental myocarditis induced in Swiss mice by homologous heart immunization resembles chronic experimental Chagas' heart disease.

  1984cited by this paper
• The Special Programme for Research and Training in Tropical Diseases

  1984cited by this paper
• A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites

  1982cited by this paper
• CHAGASIC MYOCARDIOPATHY.

  1964cited by this paper

• Trypanothione reductase inhibitors: Overview of the action of thioridazine in different stages of Chagas disease.

  2015cites this paper
• Circulating Trypanosoma cruzi populations differ from those found in the tissues of the same host during acute experimental infection.

  2014cites this paper
• Chemical compositions and properties of Schinus areira L. essential oil on airway inflammation and cardiovascular system of mice and rabbits.

  2012cites this paper
• Electrocardiography as a Diagnostic Method for Chagas Disease in Patients and Experimental Models

  2012cites this paper
• Neurodegeneration and neuroregeneration in Chagas disease.

  2011cites this paper
• Trypanosoma cruzi-Derived Neurotrophic Factor: Role in Neural Repair and Neuroprotection.

  2010cites this paper
• Trypanosoma cruzi-Induced Central Nervous System Alterations: From the Entry of Inflammatory Cells to Potential Cognitive and Psychiatric Abnormalities

  2010cites this paper